Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
Sven Strebel(University of Geneva), Claudia E. Kuehni(University of Bern), Gabriele Calaminus(University Hospital Bonn), Claire Berger(Inserm), Grit Sommer(University of Bern), Tomáš Kepák(Masaryk University), Julianne Byrne(Boyne Research Institute), Thorsten Langer, Katja Baust(University Hospital Bonn), Annette Weiß(University of Bern), Rahel Kuonen(University of Bern), Jarmila Kruseová(Charles University), Desiree Grabow(Johannes Gutenberg University Mainz), Antoinette am Zehnhoff‐Dinnesen(University of Münster)
Cited by 9
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419